Public Health - Santé Publique
84.8K views | +0 today
Follow
Public Health - Santé Publique
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from Santé Industrie Pharmaceutique
Scoop.it!

Why COVID-19 is so hard to Track #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

Why COVID-19 is so hard to Track #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance | Public Health - Santé Publique | Scoop.it

Why COVID-19 is so hard to Track

Seeker sat down with two professors of medicine to find out how COVID-19 attacks our bodies and why it’s so hard to track and control



Credit Now This


Via TechinBiz, Sandra Boyer
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from EU FUNDING OPPORTUNITIES AND PROJECT MANAGEMENT TIPS
Scoop.it!

Pitch your COVID-19 solution to Procurers from the Health-sector registration open until 17.04.2020 #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

Pitch your COVID-19 solution to Procurers from the Health-sector registration open until 17.04.2020 #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance | Public Health - Santé Publique | Scoop.it

Via nicoleta susanu
nicoleta susanu's curator insight, April 14, 2020 9:12 AM

Who can apply?

All EIC-backed SMEs working on innovative solutions and/or that answer the following pressing medium-term needs:

1. Medical devices, supply chain and logistics management: EIC companies with medical devices to help the COVID19 outbreak including, but not limited to:

  • ventilation consumables and devices;
  • personal protection equipment;
  • test kits;
  • other medical equipment etc. for adequate treatment of Covid-19;
  • development of remote visits, care and treatment, as well as distribution of devices, drugs and facilities to homecare patients;
  • increase technical capabilities of care providers and staff skills for self-supply by 3D printing, AI and other SMART solutions in special pandemic and/or emergency cases such as COVID-19.

 

2. Biotechnology / Health - Drugs, antimicrobials: EIC Beneficiaries explore new antimicrobials and drugs to tackle new virus including, but not limited to:

  • Antibacterial gel;
  • (Hydro) Chloroquine;
  • Antiretroviral drugs;
  • Lopinavir/ritonavir;
  • Azithromycin;
  • hospital related infection, rare diseases and new pandemics.